Validation of a Simple to Use PGD Prediction Algorithm

Autor: J.M. Diamond, R. Localio, A. Michelson, E. Cantu, E. Clausen, L. Kalman, M. Oyster, R. Criner, M. Anderson, R. Gallop, R. Hachem, J.D. Christie

Publikováno v: The Journal of Heart and Lung Transplantation. 41:S145

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7ab24ed9a5bcb3d514a26c46065f3ee0
https://doi.org/10.1016/j.healun.2022.01.342

Metabolic modeling using statistical and spreadsheet software: Application to the glucose minimal model

Autor: Darko Stefanovski, A. R. Localio, Raymond C. Boston, G.M. Ward, Naresh M. Punjabi, P. J. Moate, Nicholas Frank

Publikováno v: Computer methods and programs in biomedicine. 191

Kinetic non-linear metabolic models are used extensively in medical research and increasingly for clinical diagnostic purposes. An example of such a model is the Glucose Minimal Model by Bergman and colleagues [1]. This model is similar to pharmacoki

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::686f69d7e2d73000859e93608b6eda64
https://pubmed.ncbi.nlm.nih.gov/32113102

Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation

Autor: Jason D. Christie, Joshua M. Diamond, Scarlett L. Bellamy, Vibha N. Lama, Judd D. Flesch, David W. Roe, Sangeeta Bhorade, Keith M. Wille, J. Sonnet, David J. Lederer, Jonathan B. Orens, Rupal J. Shah, Ann Weinacker, Ejigayehu Demissie, A R. Localio, Steven M. Kawut, James C. Lee, Lorraine B. Ware, Scott M. Palmer, Maria Crespo, Edward Cantu, David S. Wilkes, Ashish S. Shah

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol 15, iss 8

Primary graft dysfunction (PGD) is a major cause of early mortality after lung transplant. We aimed to define objective estimates of PGD risk based on readily available clinical variables, using a prospective study of 11 centers in the Lung Transplan

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fd7d977a76899da606acbcdf52752aa
https://doi.org/10.1111/ajt.13262

Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy

Autor: V. Lo Re, Kyong-Mi Chang, Jay R. Kostman, P. De La Torre, A. R. Localio, J. J. Stern, Karam Mounzer, Valerianna Amorosa, J. S. Hafkin, Robert E. Gross, M. K. Osborn, Ian Frank

Publikováno v: Journal of Viral Hepatitis. 21:288-296

Suppression of hepatitis B virus (HBV) DNA to undetectable levels is an important goal for HIV/HBV-coinfected patients receiving anti-HBV-active antiretroviral therapy (ART), and current guidelines recommend that this outcome should be reached by one

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec290988b5cc752958f3ec86e389e3ee
https://doi.org/10.1111/jvh.12142

Clinical Decision Support and Palivizumab: A Means to Protect from Respiratory Syncytial Virus

Autor: Robert W. Grundmeier, Lihai Song, Alexander G. Fiks, Mark Ramos, Scott A. Lorch, Levon Utidjian, Annique Hogan, Jeremy J. Michel, A. R. Localio, Dean Karavite

SummaryBackground and Objectives: Palivizumab can reduce hospitalizations due to respiratory syncytial virus (RSV), but many eligible infants fail to receive the full 5-dose series. The efficacy of clinical decision support (CDS) in fostering paliviz

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d647685d7c18f6b829c2ed8d0305c0a
https://europepmc.org/articles/PMC4704044/